Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

New hope for tough lung cancer: tarlatamab takes on relapsed SCLC

NCT ID NCT05740566

Disease control Sponsor: Amgen Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing This study
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This phase 3 study compares tarlatamab, an experimental drug, to standard treatments in about 500 adults with small cell lung cancer that returned after initial chemotherapy. The main goal is to see if tarlatamab helps people live longer. Participants must have measurable disease and have progressed after one platinum-based regimen.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Phase 3

Large-scale testing in a bigger group. Usually the last step before a treatment can be approved.

Participants

509 people

The number who actually took part.

Started

May 2023

Expected to finish

Mar 2028

An estimate. End dates often move.

Lead sponsor

A company

The lead sponsor is a pharmaceutical, biotech, or medical-device company.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 years and older

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Participant has provided informed consent prior to initiation of any study specific activities/procedures. * Age ≥ 18 years (or legal adult age within country, whichever is older) at the time of signing the informed consent. * Histologically or cytologically confirmed SCLC with demonstrated progression or relapse. * Participants who progressed or recurred following 1 platinum-based regimen. * Measurable disease as defined per RECIST 1.1 within the 21-day screening period. * Eastern Cooperative Oncology Group (ECOG) PS of 0 or 1. * Minimum life expectancy of 12 weeks. * Adequate organ function. Exclusion Criteria: * Disease Related * Symptomatic central nervous system (CNS) metastases with exceptions defined in the protocol. * Diagnosis or evidence of leptomeningeal disease. * Prior history of immune checkpoint inhibitors resulting in events defined in the protocol. * Other Medical Conditions * Active autoimmune disease that has required systemic treatment (except replacement therapy) within the past 2 years or any other diseases requiring immunosuppressive therapy. * History of solid organ transplantation. * History of other malignancy within the past 2 years, with exceptions defined in the protocol. * Myocardial infarction and/or symptomatic congestive heart failure (New York Heart Association \> class II) within 12 months prior to first dose of study treatment. * History of arterial thrombosis (eg, stroke or transient ischemic attack) within 12 months prior to first dose of study treatment. * Presence or history of viral infection based on criteria per protocol. * Receiving systemic corticosteroid therapy or any other form of immunosuppressive therapy within 7 days prior to first dose of study treatment. * Symptoms and/or radiographic signs that indicate an acute and/or uncontrolled active systemic infection requiring antibiotics within 7 days prior to the first dose study treatment. * Evidence of interstitial lung disease or active, non-infectious pneumonitis. * Prior/Concomitant Therapy * Prior therapy with tarlatamab or any of the standard of care chemotherapy included as part of this trial or participation in any tarlatamab or any other DLL3 targeted agent clinical trial. * Prior therapy with any selective inhibitor of the DLL3 pathway. * Participant received more than one prior systemic therapy regimen for SCLC. * Prior anti-cancer therapy within 21 days prior to first dose of study treatment with exceptions defined in protocol. * Current anti-cancer therapy such as chemotherapy, immunotherapy, or targeted therapy with exceptions. * Use of herbal or prescription/non-prescription medications known to inhibit membrane transporters P-glycoprotein (P-gp) and/or breast cancer resistance protein (BCRP) within 7 days prior to the first dose of study treatment. * Use of herbal or prescription/non-prescription medications known to be moderate or strong inhibitors of cytochrome P450 3A (CYP3A) enzymes within 7 days prior to the first dose of study treatment. * Use of herbal or prescription/non-prescription medications known to be moderate or strong inducers of CYP3A enzymes within 28 days prior to first dose of study treatment. * Participants who have reached the limit dose of prior treatment with cardiotoxic drugs. * Major surgical procedures within 28 days prior to first dose of study treatment. * Live and live-attenuated vaccines within 14 days prior to the start of study treatment. * Inactive vaccines and live viral non-replicating vaccines within 3 days prior to the first dose of study treatment. * Currently receiving treatment in another investigational device or drug study, or less than 30 days since ending treatment on another investigational device or drug study(ies). Other investigational procedures while participating in this study are excluded. * Diagnostic Assessments * Any previous diagnosis of transformed non-small cell lung cancer (NSCLC), epidermal growth factor receptor (EGFR) activating mutation positive NSCLC that has transformed to SCLC, with exceptions defined in the protocol. * Other Exclusions * Female participants of childbearing potential unwilling to use protocol specified method of contraception during treatment and for an additional 60 days after the last dose of tarlatamab. * Female participants who are breastfeeding or who plan to breastfeed while on study through 60 days after the last dose of tarlatamab. * Female participants planning to become pregnant or donate eggs while on study through 60 days after the last dose of tarlatamab. * Female participants of childbearing potential with a positive pregnancy test assessed at screening by a serum pregnancy test. * Male participants with a female partner of childbearing potential who are unwilling to practice sexual abstinence (refrain from heterosexual intercourse) or use contraception during treatment and for an additional 60 days after the last dose of tarlatamab. * Male participants with a pregnant partner who are unwilling to practice abstinence or use a condom during treatment and for an additional 60 days after the last dose of tarlatamab. * Male participants unwilling to abstain from donating sperm during treatment and for an additional 60 days after the last dose of tarlatamab. * Contraception requirements for male and female participants receiving SOC therapies are based on regional prescribing information. * Breastfeeding restrictions for female participants receiving SOC therapies are based on regional prescribing information. * Participant has known sensitivity or is contraindicated to any of the products or components to be administered during dosing. * Participant likely to not be available to complete all protocol-required study visits or procedures, and/or to comply with all required study procedures. * History or evidence of any other clinically significant disorder, condition or disease determined by the investigator or Amgen physician that would pose a risk to the subject safety or interfere with the study evaluation..

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Small cell lung cancer ( SCLC ) are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

small cell lung carcinoma

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Small cell lung cancer ( SCLC )

Contacts and locations

Locations

  • AZ Delta Campus Rumbeke

    Roeselare, 8800, Belgium

  • Affiliated Cancer Hospital of Harbin Medical University

    Harbin, Heilongjiang, 150000, China

  • Aichi Cancer Center

    Nagoya, Aichi-ken, 464-8681, Japan

  • Alaska Oncology and Hematology

    Anchorage, Alaska, 99508, United States

  • Alexandra Hospital

    Athens, 11528, Greece

  • Anhui Chest Hospital

    Hefei, Anhui, 230022, China

  • Ankara Bilkent Sehir Hastanesi

    Ankara, 06800, Turkey (Türkiye)

  • Army Special Medical Center of Peoples Liberation Army

    Chongqing, Chongqing Municipality, 400042, China

  • Asan Medical Center

    Seoul, 05505, South Korea

  • Asklepios Fachkliniken Muenchen Gauting

    Gauting, 82130, Germany

  • Azienda Ospedaliera San Giovanni Addolorata

    Roma, 00144, Italy

  • Azienda Ospedaliera Universitaria Renato Dulbecco

    Catanzaro, 88100, Italy

  • Azienda Ospedaliera Universitaria San Luigi Gonzaga

    Orbassano, 10043, Italy

  • Bagcilar Medipol Mega Universite Hastanesi

    Istanbul, 34214, Turkey (Türkiye)

  • Baptist Cancer Center

    Memphis, Tennessee, 38120, United States

  • Beaumont Hospital

    Dublin, 9, Ireland

  • Beijing Cancer Hospital

    Beijing, Beijing Municipality, 100142, China

  • Beijing Chest Hospital, Capital Medical University

    Beijing, 101149, China

  • Beijing Tongren Hospital affiliated to Capital Medical University

    Beijing, Beijing Municipality, 100010, China

  • Beneficencia Portuguesa de Sao Paulo - Bp

    São Paulo, São Paulo, 01323-900, Brazil

  • Calvary Mater Newcastle Hospital

    Waratah, New South Wales, 2298, Australia

  • Cemic

    Ciudad Autonoma de Buenos Aires, Buenos Aires, C1431FWO, Argentina

  • Centre Hospitalier Lyon Sud

    Pierre-Bénite, 69495, France

  • Centre Hospitalier Regional Universitaire de Limoges - Hopital Dupuytren

    Limoges, 87042, France

  • Centre Hospitalier Régional Universitaire de Lille - Institut Coeur Poumon

    Lille, 59037, France

  • Centre Hospitalier Universitaire Nord

    Marseille, 13915, France

  • Centre Hospitalier Universitaire de Grenoble - Hopital Nord Michallon

    Grenoble, 38700, France

  • Centre Hospitalier Universitaire de Rennes - Hopital Pontchaillou

    Rennes, 35033, France

  • Centre Hospitalier Universitaire de Strasbourg - Nouvel Hopital Civil

    Strasbourg, 67091, France

  • Centre Hospitalier Universitaire de Toulouse - Hopital Larrey

    Toulouse, 31059, France

  • Centre Leon Berard

    Lyon, 69008, France

  • Centrul de Oncologie Sf Nectarie SRL

    Craiova, 200542, Romania

  • Centrum Pulmonologii i Torakochirurgii w Bystrej

    Bystra, 43-360, Poland

  • Charite Universitaetsmedizin Berlin, Campus Virchow

    Berlin, 13353, Germany

  • Christie Hospital

    Manchester, M20 4BX, United Kingdom

  • Chungbuk National University Hospital

    Cheongju Chungbuk, 28644, South Korea

  • Clinica Viedma

    Viedma, Río Negro Province, R8500ACE, Argentina

  • Complexo Hospitalario Universitario A Coruna Hospital Teresa Herrera

    A Coruña, Galicia, 15006, Spain

  • Ege Universitesi Tip Fakultesi Hastanesi

    Izmir, 35100, Turkey (Türkiye)

  • Erasmus Medisch Centrum

    Rotterdam, 3015 GD, Netherlands

  • European Interbalkan Medical Center

    Thessaloniki, 57001, Greece

  • Fakultni nemocnice Brno

    Brno, 625 00, Czechia

  • Fakultni nemocnice Olomouc

    Olomouc, 779 00, Czechia

  • Fejer Varmegyei Szent Gyorgy Egyetemi Oktato Korhaz

    Székesfehérvár, 8000, Hungary

  • Freiburg Spital

    Fribourg, 1708, Switzerland

  • Fudan University Shanghai Cancer Center

    Shanghai, Shanghai Municipality, 200032, China

  • Fujian Cancer Hospital

    Fuzhou, 350011, China

  • Fujian Medical University Union Hospital

    Fuzhou, Fujian, 350001, China

  • Fundacion Jimenez Diaz

    Madrid, 28040, Spain

  • Gachon University Gil Hospital

    Incheon, 21565, South Korea

  • Gazi Universitesi Saglik Arastirma ve Uygulama Merkezi Gazi Hastanesi

    Ankara, 06560, Turkey (Türkiye)

  • Goztepe Prof Dr Suleyman Yalcin Sehir Hastanesi

    Istanbul, 34722, Turkey (Türkiye)

  • Gustave Roussy

    Villejuif, 94805, France

  • Guys Hospital

    London, SE1 9RT, United Kingdom

  • Gyeongsang National University Hospital

    Jinju, 52727, South Korea

  • Hadassah Ein-Kerem Medical Center

    Jerusalem, 9112001, Israel

  • Health Pharma Professional Research SA de CV

    Mexico City, Mexico City, 03100, Mexico

  • Henry Dunant Hospital Center

    Athens, 11526, Greece

  • Hopitaux universitaires de Geneve

    Geneva, 1211, Switzerland

  • Hospital Clinico San Carlos

    Madrid, 28040, Spain

  • Hospital Clinico Universitario Lozano Blesa

    Zaragoza, Aragon, 50009, Spain

  • Hospital Cuf Descobertas

    Lisbon, 1998-018, Portugal

  • Hospital Cuf porto

    Porto, 4100-180, Portugal

  • Hospital Regional Universitario de Malaga

    Málaga, Andalusia, 29011, Spain

  • Hospital Santa Izabel

    Salvador, Estado de Bahia, 40050-410, Brazil

  • Hospital Sao Lucas da Pontificia Universidade Catolica do Rio Grande do Sul

    Porto Alegre, Rio Grande do Sul, 90610-000, Brazil

  • Hospital Tengku Ampuan Afzan

    Kuantan, Pahang, 25100, Malaysia

  • Hospital Universitari Vall d Hebron

    Barcelona, Catalonia, 08035, Spain

  • Hospital Universitario 12 de Octubre

    Madrid, 28041, Spain

  • Hospital Universitario Austral

    Pilar, Buenos Aires, B1629ODT, Argentina

  • Hospital Universitario Puerta de Hierro Majadahonda

    Majadahonda, Madrid, 28222, Spain

  • Hospital da Luz, SA

    Lisbon, 1500-650, Portugal

  • Hospital de Amor da Amazonia

    Porto Velho, Rondônia, 76834-899, Brazil

  • Hospital de Base de Sao Jose do Rio Preto

    São José do Rio Preto, São Paulo, 15090-000, Brazil

  • Hospital de la Santa Creu i Sant Pau

    Barcelona, Catalonia, 08041, Spain

  • Hospital del Mar

    Barcelona, Catalonia, 08003, Spain

  • Humanitas Gavazzeni

    Bergamo, 24125, Italy

  • Hunan Cancer Hospital

    Changsha, Hunan, 410013, China

  • Hyogo Cancer Center

    Akashi-shi, Hyōgo, 673-8558, Japan

  • Indiana University

    Indianapolis, Indiana, 46202, United States

  • Inonu Universitesi Turgut Ozal Tip Merkezi

    Malatya, 44280, Turkey (Türkiye)

  • Institut Curie

    Paris, 75005, France

  • Instituto Argentino de Diagnostico y Tratamiento IADT

    Buenos Aires, C1122AAL, Argentina

  • Instituto Coi

    Rio de Janeiro, 22793-080, Brazil

  • Instituto de Ensino e Pesquisa do Hospital da Bahia

    Salvador, Estado de Bahia, Brazil

  • Instituto do Cancer do Estado de Sao Paulo Octavio Frias de Oliveira Icesp

    São Paulo, 01246-000, Brazil

  • Institutul Oncologic Prof Dr Ion Chiricuta Cluj-Napoca

    Cluj-Napoca, 400015, Romania

  • Institutul Regional de Oncologie Iasi

    Iași, 700483, Romania

  • Istituto Romagnolo per lo Studio dei Tumori Dino Amadori

    Meldola (FC), 47014, Italy

  • Izmir Ekonomi Universitesi Medical Point Hastanesi

    Izmir, 35575, Turkey (Türkiye)

  • Jessa Ziekenhuis - Campus Virga Jesse

    Hasselt, 3500, Belgium

  • Jiangmen Central Hospital

    Jiangmen, Guangdong, 529030, China

  • Jilin Cancer Hospital

    Changchun, Jilin, 130012, China

  • Jinan Central Hospital

    Jinan, Shandong, 250013, China

  • Juntendo University Hospital

    Bunkyo-ku, Tokyo, 113-8431, Japan

  • Kanagawa Prefectural Hospital Organization Kanagawa Cancer Center

    Yokohama, Kanagawa, 241-8515, Japan

  • Kansai Medical University Hospital

    Hirakata-shi, Osaka, 573-1191, Japan

  • Kantonsspital Graubuenden

    Chur, 7000, Switzerland

  • Kantonsspital Sankt Gallen

    Sankt Gallen, 9007, Switzerland

  • Kantonsspital Winterthur

    Winterthur, 8401, Switzerland

  • Kaohsiung Medical University Chung-Ho Memorial Hospital

    Kaohsiung City, 80756, Taiwan

  • Kindai University Hospital

    Osakasayama-shi, Osaka, 589-8511, Japan

  • Komarom-Esztergom Varmegyei Szent Borbala Korhaz

    Tatabánya, 2800, Hungary

  • Kurume University Hospital

    Kurume-shi, Fukuoka, 830-0011, Japan

  • Leids Universitair Medisch Centrum

    Leiden, 2333 ZA, Netherlands

  • Liga Norte-Riograndense Contra O Cancer

    Natal, Rio Grande do Norte, 59075-740, Brazil

  • Linyi Cancer Hospital

    Linyi, Shandong, 276034, China

  • Liverpool Hospital

    Liverpool, New South Wales, 2170, Australia

  • London Health Sciences Centre

    London, Ontario, N6A 5W9, Canada

  • LungenClinic Grosshansdorf GmbH

    Großhansdorf, 22927, Germany

  • Masarykuv onkologicky ustav

    Brno, 656 53, Czechia

  • Matrai Gyogyintezet

    Gyöngyös, 3200, Hungary

  • Medizinische Universitaet Graz

    Graz, 8036, Austria

  • Meir Medical Center

    Kfar Saba, 4428164, Israel

  • Memorial Ankara Hastanesi

    Ankara, 06520, Turkey (Türkiye)

  • Memorial Sloan Kettering Cancer Center

    New York, New York, 10021, United States

  • Mengchao Hepatobiliary Hospital of Fujian Medical University

    Fuzhou, Fujian, 350025, China

  • Monash Medical Centre

    Clayton, Victoria, 3168, Australia

  • National Cancer Center

    Goyang-si Gyeonggi-do, 10408, South Korea

  • National Cancer Center Hospital

    Chuo-ku, Tokyo, 104-0045, Japan

  • National Cancer Center Hospital East

    Kashiwa-shi, Chiba, 277-8577, Japan

  • National Cancer Centre Singapore

    Singapore, 168583, Singapore

  • National Cheng Kung University Hospital

    Tainan, 70403, Taiwan

  • National Hospital Organization Hokkaido Cancer Center

    Sapporo, Hokkaido, 003-0804, Japan

  • National Hospital Organization Nagoya Medical Center

    Nagoya, Aichi-ken, 460-0001, Japan

  • National Hospital Organization Shikoku Cancer Center

    Matsuyama, Ehime, 791-0280, Japan

  • National Taiwan University Hospital

    Taipei, 10002, Taiwan

  • Nemocnice Agel Ostrava-Vitkovice as

    Ostrava-Vitkovice, 703 00, Czechia

  • New York University Grossman School of Medicine and New York University Langone Hospitals

    New York, New York, 10016, United States

  • Niigata Cancer Center Hospital

    Niigata, Niigata, 951-8566, Japan

  • Northport Veterans Affairs Medical Center

    Northport, New York, 11768, United States

  • Northwestern University

    Chicago, Illinois, 60611, United States

  • Okayama University Hospital

    Okayama, Okayama-ken, 700-8558, Japan

  • Olympion Therapeftirio General Clinic Of Patras

    Pátrai, 26443, Greece

  • Oncare

    Mexico City, Mexico City, 03810, Mexico

  • Oncologia Rede D Or

    São Paulo, São Paulo, 04502-001, Brazil

  • Oncosite Centro de Pesquisa Clinica Em Oncologia Ltda

    Ijuí, Rio Grande do Sul, 98700-000, Brazil

  • Orszagos Koranyi Pulmonologiai Intezet

    Budapest, 1121, Hungary

  • Osaka International Cancer Institute

    Osaka, Osaka, 541-8567, Japan

  • Ospedale Policlinico San Martino IRCCS

    Genova, 16132, Italy

  • Our Lady of the Lake Cancer Institute

    Baton Rouge, Louisiana, 70808, United States

  • Pamukkale Universitesi Tip Fakultesi Hastanesi

    Denizli, 20070, Turkey (Türkiye)

  • Perlmutter Cancer Center at New York University Langone Hospital----Long Island

    New York, New York, 10016, United States

  • Pikeville Medical Center

    Pikeville, Kentucky, 41501, United States

  • Princess Margaret Cancer Centre

    Toronto, Ontario, M5G 2M9, Canada

  • Rabin Medical Center

    Petah Tikva, 4941492, Israel

  • Rambam Medical Center

    Haifa, 3109601, Israel

  • Reformatus Pulmonologiai Centrum

    Törökbálint, 2045, Hungary

  • Rigshospitalet

    Copenhagen, 2100, Denmark

  • Robert-Bosch-Krankenhaus

    Stuttgart, 70376, Germany

  • SC Oncomed SRL

    Timișoara, 300239, Romania

  • Saint Luke Hospital

    Thessaloniki, 55236, Greece

  • Saint Savas Hospital

    Athens, 11522, Greece

  • Saitama Medical University International Medical Center

    Hidaka-Shi, Saitama, 350-1298, Japan

  • Samsung Medical Center

    Seoul, 06351, South Korea

  • Sanatorio Allende

    Córdoba, X5000JHQ, Argentina

  • Sanatorio Parque SA

    Rosario, Santa Fe Province, 2000, Argentina

  • Sanford Oncology Clinic and Pharmacy

    Sioux Falls, South Dakota, 57104, United States

  • Sanford Roger Maris Cancer Center

    Fargo, North Dakota, 58102, United States

  • Sarawak General Hospital

    Kuching, Sarawak, 93586, Malaysia

  • Semmelweis Egyetem

    Budapest, 1083, Hungary

  • Sendai Kousei Hospital

    Sendai, Miyagi, 981-0914, Japan

  • Seoul National University Bundang Hospital

    Seongnam-si, Gyeonggi-do, 13620, South Korea

  • Severance Hospital Yonsei University Health System

    Seoul, 03722, South Korea

  • Shandong Tumor Hospital

    Jinan, Shandong, 250117, China

  • Shanghai Chest Hospital

    Shanghai, Shanghai Municipality, 200030, China

  • Shanxi Province Cancer Hospital

    Taiyuan, Shanxi, 30009, China

  • Shizuoka Cancer Center

    Sunto-gun, Shizuoka, 411-8777, Japan

  • Sociedad de Beneficencia Hospital Italiano

    Córdoba, Córdoba Province, X5004BAL, Argentina

  • Subei Peoples Hospital

    Yangzhou, Jiangsu, 225009, China

  • Summit Medical Group, Overlook Oncology Center

    Summit, New Jersey, 91010, United States

  • Sun Yat-Sen University Cancer Center

    Guangzhou, Guangdong, 510060, China

  • Swedish Cancer Institute Medical Oncology

    Edmonds, Washington, 98026, United States

  • Szpital Specjalistyczny imienia Ludwika Rydygiera w Krakowie Sp zoo

    Krakow, 31-826, Poland

  • Taipei Veterans General Hospital

    Taipei, 11217, Taiwan

  • Taizhou Hospital of Zhejiang Province

    Taizhou, Zhejiang, 317099, China

  • Tan Tock Seng Hospital

    Singapore, 308433, Singapore

  • The 4th Hospital of Hebei Medical University

    Shijiazhuang, Hebei, 050000, China

  • The Alfred Hospital

    Melbourne, Victoria, 3004, Australia

  • The Cancer Institute Hospital of Japanese Foundation for Cancer Research

    Koto-ku, Tokyo, 135-8550, Japan

  • The Catholic University of Korea Seoul St Marys Hospital

    Seoul, 06591, South Korea

  • The First Affiliated Hospital Zhejiang University School of Medicine

    Hangzhou, Zhejiang, 310003, China

  • The First Affiliated Hospital of Nanchang University

    Nanchang, Jiangxi, 330006, China

  • The First Affiliated Hospital of Wenzhou Medical University

    Wenzhou, Zhejiang, 325015, China

  • The Medical College of Wisconsin

    Milwaukee, Wisconsin, 53226, United States

  • The Second Affiliated Hospital Zhejiang University School of Medicine

    Hangzhou, Zhejiang, 310003, China

  • The Second Affiliated Hospital of Army Medical University, PLA

    Chongqing, Chongqing Municipality, 400037, China

  • Thoracic General Hospital Of Athens Sotiria

    Athens, 11527, Greece

  • Tianjin Peoples Hospital

    Tianjin, 300131, China

  • Tongji Hospital Tongji Medical College Huazhong University of Science and Technology

    Wuhan, Hubei, 430030, China

  • Trinity Health Saint Joseph Mercy Ann Arbor

    Ann Arbor, Michigan, 48106, United States

  • Ulsan University Hospital

    Ulsan, 44033, South Korea

  • Unidade Local de Saude de Matosinhos, EPE - Hospital Pedro Hispano

    Matosinhos Municipality, 4464-513, Portugal

  • Union Hospital Tongji Medical College Huazhong University of Science and Technology

    Wuhan, Hubei, 430022, China

  • Universitaetsklinikum Dresden

    Dresden, 01307, Germany

  • Universitaetsklinikum Essen

    Essen, 45147, Germany

  • Universitaetsklinikum Koeln

    Cologne, 50937, Germany

  • Universitaetsklinikum Krems

    Krems, 3500, Austria

  • Universitaetsklinikum Wuerzburg

    Würzburg, 97078, Germany

  • Universitair Medisch Centrum Groningen

    Groningen, 9713 GZ, Netherlands

  • Universitair Medisch Centrum Utrecht

    Utrecht, 3584 CX, Netherlands

  • Universitair Ziekenhuis Gent

    Ghent, 9000, Belgium

  • University College London Hospital

    London, NW1 2PG, United Kingdom

  • University Hospital of Heraklion

    Heraklion - Crete, 71500, Greece

  • University Malaya Medical Centre

    Kuala Lumpur, Kuala Lumpur, 59100, Malaysia

  • University of Arkansas for Medical Sciences

    Little Rock, Arkansas, 72205, United States

  • University of California Los Angeles

    Santa Monica, California, 90404, United States

  • University of Illinois Chicago

    Chicago, Illinois, 60612, United States

  • University of Iowa

    Iowa City, Iowa, 52242, United States

  • University of Minnesota Cancer Center

    Minneapolis, Minnesota, 55455, United States

  • University of Missouri Health Care

    Columbia, Missouri, 65212, United States

  • University of South Alabama Mitchell Cancer Institute

    Mobile, Alabama, 36604, United States

  • University of Tennessee Medical Center Knoxville

    Knoxville, Tennessee, 37920, United States

  • Veterans General Hospital - Taichung

    Taichung, 40705, Taiwan

  • Virginia Commonwealth University

    Richmond, Virginia, 23298, United States

  • Vitaz campus Sint-Niklaas Moerland

    Sint-Niklaas, 9100, Belgium

  • Vseobecna fakultni nemocnice v Praze

    Prague, 128 08, Czechia

  • Wakayama Medical University Hospital

    Wakayama, Wakayama, 641-8510, Japan

  • Weihai Municipal Hospital

    Weihai, 264200, China

  • West China Hospital of Sichuan University

    Chengdu, Sichuan, 610041, China

  • Wielkopolskie Centrum Pulmonologii i Torakochirurgii imienia Eugenii i Janusza Zeylandow

    Poznan, 60-569, Poland

  • Zhejiang Cancer Hospital

    Hangzhou, Zhejiang, 310005, China

  • coi Centro Oncologico Internacional sapi de cv

    Tlajomulco de Zúñiga, Jalisco, 45640, Mexico

More trials for these conditions

Other studies related to the condition(s) this trial covers.